Anna Dart

Former scientist, now Chief Editor @NatureRevCancer; love playing hockey; views are my own.

[Nature Reviews Cancer @NatureRevCancer]

Make sure to register for this exciting meeting in London on the 17-19th June exploring cancer and its interactions with the host....final few places available. Our Chief Editor Anna Dart will be there👇

[Anna Dart @annaedart]

Check out our latest Focus issue highlighting why the mechanisms of ageing, which contribute to cancer development, progression & treatment are so important in our rapidly ageing global population 👇

[Nature Reviews Cancer @NatureRevCancer]

New online: #Focus on ageing and cancer

Today, on #WorldCancerResearchDay we publish the first of our two focus issues highlighting current research at the intersection between #ageing and #cancer.

Read all about it in our #editorial 👇
https://t.co/1j0klqdgcR

[Gomes Lab @lab_gomes]

Super excited to share our newest piece out today @NatureRevCancer linking age-induced metabolic reprogramming to cancer development. https://t.co/MbiKYAAAkg

[Nature Reviews Cancer @NatureRevCancer]

Our July issue is LIVE! 🌞🥵🏖️

It features articles on:
- Targeted protein degradation for cancer therapy
- Advances in therapeutic cancer vaccines
- The TGFβ paradox in HPV-driven cancer
- The paths to metastasis

Happy reading! 👇 📖
https://t.co/qSXVAVaSoa

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Endoplasmic reticulum stress responses in anticancer immunity https://t.co/M1D5S5JwHw

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Neuro-immune cross-talk in cancer https://t.co/f0OjQwkrA5

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Regulatory T cells in the tumour microenvironment https://t.co/9VxXLOY7EG

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy https://t.co/HGb5SJipFn

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Acquired resistance in cancer: towards targeted therapeutic strategies https://t.co/4xpw2J3dvg

[Nature Reviews Cancer @NatureRevCancer]

Our Chief Editor @annaedart will be attending and what's more, it's free so make sure you sign up to come discuss all things cancer! 👇

[Nature Reviews Cancer @NatureRevCancer]

NEW content online! Targeted protein degradation for cancer therapy https://t.co/ytJi2DsmKZ

[Andreana N. Holowatyj @drholowatyj]

We're "hunting a rare cancer" 🍃🗺️‼️
How? Get the FREE article here: https://t.co/TQVL1nAHaQ

Inspired by the first-ever research 'map' for #appendicealcancer to chart us to groundbreaking discoveries for our patients, 🔎 at creative cover art on the @NatureRevCancer April issue!

[Nature Reviews Cancer @NatureRevCancer]

🚨 Our April issue is LIVE! 🌻 🌦️

It features articles on:
- DC maturation in cancer
- Cross-priming in cancer immunology & immunotherapy
- Metabolic interplays between tumour & host
- A 'cells to society' research framework for appendix cancer

📖👉 https://t.co/1AYORdVXaf

[Nature Reviews Cancer @NatureRevCancer]

At the #KSTumorMetab25 meeting?

Check out the latest review by Ayelet Erez & colleagues for more details on how metabolic interplay between the tumour & the host shape the tumour macroenvironment.

👀⬇️
https://t.co/JwUTgJEhKM

[Nature Reviews Cancer @NatureRevCancer]

In case you missed it: #Review
@drholowatyj & Co cover the current state of the field in #AppendicealCancer and propose a conceptual research framework to advance knowledge of this rare cancer.
@acpmpresearch
📖👇
https://t.co/jafOBmAvZ5

[Nature Reviews Cancer @NatureRevCancer]

FINALLY 🥁.. our top most downloaded article of the year is…. 🥁 🥁🥁

Why do patients with cancer die? By @thomasrcox, Eric Sahai and colleagues

https://t.co/q8xFgq6ZWC

@crick.ac.uk @natrescancer @GarvanInstitute @UNSW @TheCrick
@NatResCancer #NRCtop10of2024

[Anna Dart @annaedart]

And the moment you have all been waiting for...our top downloaded article of 2024! Well worth a read!

[Nature Reviews Cancer @NatureRevCancer]

FINALLY 🥁.. our top most downloaded article of the year is…. 🥁 🥁🥁

Why do patients with cancer die? By @thomasrcox, Eric Sahai and colleagues

https://t.co/q8xFgq6ZWC

@crick.ac.uk @natrescancer @GarvanInstitute @UNSW @TheCrick
@NatResCancer #NRCtop10of2024

[Nature Reviews Cancer @NatureRevCancer]

🥳 Our 2nd most downloaded article in 2024:

Cancer therapy with antibodies by Paul, Gabelli, @MitchellHo, van Elsas & colleagues

https://t.co/J3O3OnSEjN

@JohnHopkins @theNCI @NIH @NatResCancer #NRCtop10of2024

[Nature Reviews Cancer @NatureRevCancer]

🥳 Our 3rd most downloaded article in 2024:

A guide to artificial intelligence for cancer researchers by @RaqPerezLopez, @GhaffariNarmin, @AI4Pathology & @jnkath

https://t.co/qF6cvIZQxo

@Medizin_TUD, @NCT_HD, @DataScienceDKFZ, @katherlab
@NatResCancer #NRCtop10of2024

[Nature Reviews Cancer @NatureRevCancer]

🥳 Our 4th most downloaded article in 2024:

Beyond genetics: driving cancer with the tumour microenvironment behind the wheel by @ElaineFuchsLab, Shaopeng Yuan & Jorge Almagro

https://t.co/Zdyfj7va3d

@RockefellerUniv @NatResCancer #NRCtop10of2024